52 related articles for article (PubMed ID: 35027319)
1. An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
Vranic S; Gatalica Z
Clin Breast Cancer; 2022 Jun; 22(4):e576-e585. PubMed ID: 35027319
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast.
Jones C; Damiani S; Wells D; Chaggar R; Lakhani SR; Eusebi V
Am J Pathol; 2001 Jan; 158(1):207-14. PubMed ID: 11141494
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion.
Lenskaya V; Yang RK; Cho WC
J Cutan Pathol; 2024 Jun; 51(6):419-423. PubMed ID: 38468567
[TBL] [Abstract][Full Text] [Related]
4. All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4.
Shousha S; Anscombe O; McFarlane T
Pathol Oncol Res; 2020 Apr; 26(2):1073-1078. PubMed ID: 31044387
[TBL] [Abstract][Full Text] [Related]
5. Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy-A case report.
Collette F; Hamoir M; Van Eeckhout P; D'Abadie P; Duprez T; Schmitz S; Machiels JP
Clin Case Rep; 2020 Dec; 8(12):3472-3478. PubMed ID: 33363954
[TBL] [Abstract][Full Text] [Related]
6. Apocrine Breast Cancer: A Case Report.
Samba S; Bensghier A; Berhili S; Moukhlissi M; Mezouar L
Cureus; 2024 Apr; 16(4):e57789. PubMed ID: 38721213
[TBL] [Abstract][Full Text] [Related]
7. Synchronous bilateral breast cancer diagnosed with primary breast apocrine carcinoma and invasive breast cancer: A rare case report.
Lv H; Kong J; Liu W; Song C
Asian J Surg; 2024 Mar; ():. PubMed ID: 38538391
[No Abstract] [Full Text] [Related]
8. Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer.
Kim JY; Park S; Cho EY; Lee JE; Jung HH; Chae BJ; Kim SW; Nam SJ; Cho SY; Park YH; Ahn JS; Lee S; Im YH
Exp Mol Med; 2023 Jul; 55(7):1451-1461. PubMed ID: 37394589
[TBL] [Abstract][Full Text] [Related]
9. Rare subtypes of triple negative breast cancer: Current understanding and future directions.
Thomas A; Reis-Filho JS; Geyer CE; Wen HY
NPJ Breast Cancer; 2023 Jun; 9(1):55. PubMed ID: 37353557
[TBL] [Abstract][Full Text] [Related]
10. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.
Schwartz CJ; Ruiz J; Bean GR; Sirohi D; Joseph NM; Hosfield EM; Jacobs TW; Mukhtar RA; Chen YY; Krings G
Mod Pathol; 2023 May; 36(5):100125. PubMed ID: 36870308
[TBL] [Abstract][Full Text] [Related]
11. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy.
Hu T; Liu Y; Wu J; Hu XL; Zhao G; Liang B; Wang S; Long M
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329934
[TBL] [Abstract][Full Text] [Related]
12. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative Breast Carcinoma With Apocrine and Histiocytoid Features: A Clinicopathologic and Molecular Study of 18 Cases.
Wang Y; Hacking SM; Li Z; Graff SL; Yang D; Tan L; Liu F; Zhang T; Zhao Z; Luo S; Du P; Jia S; Cheng L
Am J Surg Pathol; 2023 Sep; 47(9):1011-1018. PubMed ID: 37310016
[TBL] [Abstract][Full Text] [Related]
14. An update on the pathological classification of breast cancer.
Rakha EA; Tse GM; Quinn CM
Histopathology; 2023 Jan; 82(1):5-16. PubMed ID: 36482272
[TBL] [Abstract][Full Text] [Related]
15. Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast.
Ji J; Zhang F; Duan F; Yang H; Hou J; Liu Y; Dai J; Liao Q; Chen X; Liu Q
Sci Rep; 2022 May; 12(1):8504. PubMed ID: 35590093
[TBL] [Abstract][Full Text] [Related]
16. HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome.
Skenderi F; Alahmad MAM; Tahirovic E; Alahmad YM; Gatalica Z; Vranic S
Breast Cancer Res Treat; 2022 Jun; 193(2):523-533. PubMed ID: 35355162
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Characteristics and Prognosis of Triple-Negative Apocrine Carcinoma: A Case-Control Study.
Suzuki C; Yamada A; Kawashima K; Sasamoto M; Fujiwara Y; Adachi S; Oshi M; Wada T; Yamamoto S; Shimada K; Ota I; Narui K; Sugae S; Shimizu D; Tanabe M; Chishima T; Ichikawa Y; Ishikawa T; Endo I
World J Oncol; 2023 Dec; 14(6):551-557. PubMed ID: 38022398
[TBL] [Abstract][Full Text] [Related]
18. The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status.
Gatalica Z; Kuzmova N; Rose I; Ulamec M; Peric-Balja M; Skenderi F; Vranic S
Biomol Biomed; 2024 Mar; 24(2):256-261. PubMed ID: 37782562
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
